KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Biogen (BIIB) Deferred Taxes (2016 - 2026)

Biogen has reported Deferred Taxes over the past 18 years, most recently at $23.6 million for Q1 2026.

For Q1 2026, Deferred Taxes rose 184.89% year-over-year to $23.6 million; the TTM value through Mar 2026 reached $413.0 million, up 282.91%, while the annual FY2025 figure was $361.6 million, 328.72% up from the prior year.
Deferred Taxes for Q1 2026 was $23.6 million at Biogen, down from $166.9 million in the prior quarter.
Over five years, Deferred Taxes peaked at $253.8 million in Q3 2025 and troughed at -$206.8 million in Q3 2023.
A 5-year average of -$14.5 million and a median of -$31.3 million in 2025 define the central range for Deferred Taxes.
Biggest five-year swings in Deferred Taxes: tumbled 6550.0% in 2023 and later skyrocketed 582.51% in 2025.
Year by year, Deferred Taxes stood at -$28.8 million in 2022, then skyrocketed by 349.65% to $71.9 million in 2023, then tumbled by 181.22% to -$58.4 million in 2024, then soared by 385.79% to $166.9 million in 2025, then crashed by 85.86% to $23.6 million in 2026.
Business Quant data shows Deferred Taxes for BIIB at $23.6 million in Q1 2026, $166.9 million in Q4 2025, and $253.8 million in Q3 2025.